MANA PHARMA S.L., is dedicated to being part of the solution, supporting Hospitals and Healthcare Centers in their mission to provide uninterrupted, high-quality care.
Medicine Shortages and the Response from the AEMPS
The Spanish Agency of Medicines and Medical Devices (AEMPS), in coordination with the Ministry of Health, is actively working to mitigate the impact of medicine shortages in Spain.
Among its initiatives are the continuous monitoring and control of critical medicine supplies, as well as seeking solutions in collaboration with importers. These actions aim to reduce shortages of vital medicines for ongoing treatments, thereby safeguarding Public Health.
MANA PHARMA: Ensuring Quality of Medicines
MANA PHARMA helps to overcome this difficulty by importing high-quality medicines from numerous sources worldwide, ensuring they meet essential standards of Quality, Safety, and Efficacy. We guarantee that all medicines meet strict standards to prevent prescription errors, ensuring that both dosage and pharmaceutical form, as well as labeling language are clear, precise l and adapted to the Hospital setting in Spain.
Our transport and storage processes also follow strict temperature control and security protocols, minimizing risks and ensuring that the final product arrives at its destination in optimal condition.
In this way, we contribute to enabling hospitals to manage treatments with complete confidence in both the safety and effectiveness of the medicines provided.
Efficient National Distribution: 24/48-Hour Delivery
Efficiency in distribution is another priority for us. In a country with Spain’s diverse geography, the ability to deliver medicines within 24 to 48 hours to any region is essential for hospital care.
Thanks to our extensive logistics network, we can cover the entire national territory with rapid response times, providing critical support in urgent situations.
This is possible due to our advanced logistics management, which allows us to respond to hospital’s needs swiftly, with the flexibility to adapt to the variable demand in each area.
Impact on Patient Health in Spain
Our commitment to quality and efficiency in medicine supply has allowed us to support, indirectly, the treatment of a range of conditions affecting the Spanish population. These include serious diseases like cancer and tuberculosis, as well as preventive care through vaccines and support for treatments for neurological disorders. In each of these cases, timely and secure availability of medicines is a crucial factor in improving treatment outcomes and patient’s quality of life.
In this context, MANA PHARMA, as Marketing Authorization Holder (MAH), works constantly to ensure that new, often critical medicines without alternatives in the market, can be imported under a special authorization in Spain. In doing so, we enable more people to access treatments for their conditions, ensuring a safe and continuous supply.
Conclusion
MANA PHARMA is committed to providing hospitals throughout Spain with a continuous supply of quality medicines through agile and effective management. Our work enables hospitals to focus on what truly matters: Caring for their patients without the concern of potential shortages. We trust that our dedication and responsiveness to the needs of the healthcare sector will continue to make a difference in healthcare in Spain.
